In recent years, our knowledge regarding the metabolism of melanoma has greatly advanced and consequently
new therapeutic strategies are being developed. This review is focused on metabolic pathways contributing to melanoma
proliferation, the influence of BRAF inhibitors on those metabolic pathways and finally a presentation of potential
therapeutic strategies aimed at blocking metabolic signaling pathways and therefore melanoma development.